Screener
Beam Therapeutics BEAM PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Beam Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Beam Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:22 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210338
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Marketable securities | 923,361 | 950,266 |
| Prepaid expenses and other current assets | 55,301 | 23,478 |
| Total current assets | 1,266,953 | 1,268,688 |
| Property and equipment, net | 101,247 | 104,500 |
| Restricted cash | 6,693 | 6,676 |
| Operating lease right-of-use assets | 98,148 | 100,679 |
| Other assets | 7,757 | 634 |
| Total assets | $1,480,798 | $1,481,177 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Beam Therapeutics's PP&E (net)?
- Beam Therapeutics (BEAM) reported PP&E (net) of $101.25M in Q1 2026.
- How has Beam Therapeutics's PP&E (net) changed year-over-year?
- Beam Therapeutics's PP&E (net) decreased by 7.6% year-over-year, from $109.57M to $101.25M.
- What is the long-term trend for Beam Therapeutics's PP&E (net)?
- Over 5 years (2020 to 2025), Beam Therapeutics's PP&E (net) has grown at a 22.1% compound annual growth rate (CAGR), from $38.51M to $104.5M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Beam Therapeutics's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude